Smith SD, Sundaram S, Giri S, Ness A, et al. Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma. Am J Hematol 2026 Jun 17. doi: 10.1002/ajh.70406.
PMID: 42305039